Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Lenvatinib (mesylate) | 857890-39-2 | 99.7% | 522.96 | 10 MM * 1 ML
Supplier: Medchemexpress LLC HY10981A100MG
Lenvatinib mesylate (E7080 mesylate) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, demonstrating potent antitumor activities.
- Oral, multi-targeted tyrosine kinase inhibitor
- Potent antitumor activities
- Inhibits various receptors including VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET
- Soluble in DMSO
- Available in different in vivo solubility formulations
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?